Back to Search
JOHN HOUSTON, M.D.
M.D.
Internal Medicine Physician
NPI: 1366450447Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
7442(AZ)
Research & Publications (20)
Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996).
PMID 19564636·Blood·2009
3-trial
Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
PMID 19196847·Drug Metab Dispos·2009
8-other
Nanomechanical contrasts of gel and fluid phase supported lipid bilayers.
PMID 19534482·J Phys Chem B·2009
8-other
Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes.
PMID 18832476·Drug Metab Dispos·2009
8-other
Suspected malignant cord compression - improving time to diagnosis via a 'hotline': a prospective audit.
PMID 19471276·Br J Cancer·2009
5-case
Methodological uncertainty in quantitative prediction of human hepatic clearance from in vitro experimental systems.
PMID 19442091·Curr Drug Metab·2009
6-review
Efficient and effective compound management to support lead optimization.
PMID 19483145·J Biomol Screen·2009
8-other
A family of fibrinogen-binding MSCRAMMs from Enterococcus faecalis.
PMID 19389755·Microbiology (Reading)·2009
7-preclinical
Early symptom change prediction of remission in depression treatment.
PMID 19204654·Psychopharmacol Bull·2009
4-observational
Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia.
PMID 19451915·Pharmacogenomics J·2009
4-observational
Best practices in compound management for preserving compound integrity and accurately providing samples for assays.
PMID 19483144·J Biomol Screen·2009
8-other
Methodology for development of a physiological model incorporating CYP3A and P-glycoprotein for the prediction of intestinal drug absorption.
PMID 18855913·J Pharm Sci·2009
8-other
Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression.
PMID 19079815·Int J Neuropsychopharmacol·2009
2-rct
Relative importance of intestinal and hepatic glucuronidation-impact on the prediction of drug clearance.
PMID 19184618·Pharm Res·2009
8-other
Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder.
PMID 19095219·Biol Psychiatry·2009
2-rct
Transformation of meta-stable calcium silicate hydrates to tobermorite: reaction kinetics and molecular structure from XRD and NMR spectroscopy.
PMID 19144195·Geochem Trans·2009
8-other
Grapefruit juice-drug interaction studies as a method to assess the extent of intestinal availability: utility and limitations.
PMID 18855612·Curr Drug Metab·2008
6-review
Methods for predicting in vivo pharmacokinetics using data from in vitro assays.
PMID 18991591·Curr Drug Metab·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 500 N. HIGHWAY 89
PRESCOTT, AZ 86313 - Phone
- (928) 445-4860
Quick Facts
- NPI
- 1366450447
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile